BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular DiseasesPRNewsWire • 12/16/21
BioMarin Appoints Former CEO of Celgene Corporation, Mark Alles, to Board of DirectorsPRNewsWire • 12/15/21
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 22 Deadline in Securities Class Action - BMRNPRNewsWire • 12/15/21
BMRN Investor Notice: Rosen, a Global and Leading Law Firm, Encourages BioMarin Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 22 Deadline in Securities Class Action - BMRNNewsfile Corp • 12/09/21
UPCOMING DEADLINE: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNewsfile Corp • 12/08/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of BioMarin Pharmaceutical Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2021 - BMRNNewsfile Corp • 12/05/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Before Important December 22 Deadline in Securities Class Action - BMRNPRNewsWire • 12/05/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/04/21
Rosen, National Trial Lawyers, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important December 22 Deadline in Securities Class Action - BMRNNewsfile Corp • 12/02/21
BMRN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving BioMarin Pharmaceutical Inc.Newsfile Corp • 12/02/21
BMRN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 22, 2021 in the Class Action Filed on Behalf of BioMarin Pharmaceutical Inc. Limited ShareholdersNewsfile Corp • 12/02/21
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioMarin Pharmaceutical Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2021 - (BMRN)Newsfile Corp • 12/01/21
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/29/21
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - BMRNPRNewsWire • 11/24/21
Levi & Korsinsky, LLP, Researching Possible Securities Law Violations - BioMarin Pharmaceutical Inc. - BMRNPRNewsWire • 11/24/21
BioMarin Pharmaceutical (BMRN) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 11/24/21
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 11/24/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/23/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/22/21
